Intrapulmonary concentrations of meropenem administered by continuous infusion in critically ill patients with nosocomial pneumonia: a randomized pharmacokinetic trial

BACKGROUND: Optimal antimicrobial drug exposure in the lung is required for successful treatment outcomes for nosocomial pneumonia. Little is known about the intrapulmonary pharmacokinetics (PK) of meropenem when administered by continuous infusion (CI). The aim of this study was to evaluate the PK...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Crit Care
Hlavní autoři: Benítez-Cano, Adela, Luque, Sonia, Sorlí, Luisa, Carazo, Jesús, Ramos, Isabel, Campillo, Nuria, Curull, Víctor, Sánchez-Font, Albert, Vilaplana, Carles, Horcajada, Juan P., Adalia, Ramón, Bermejo, Silvia, Samsó, Enric, Hope, William, Grau, Santiago
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2020
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7026992/
https://ncbi.nlm.nih.gov/pubmed/32066497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-020-2763-4
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky